SynBioBeta 2014

I’m looking forward to seeing around a hundred members at our London Breakfast this Wednesday morning. I hope this informal event will enable you to network effectively and catch up on some of the issues affecting our sector. R+D Tax credits, access to finance and the planned early access scheme often come up but I imagine we might discuss the decision by the NHS to delay the introduction of its care.data system until the autumn. This has been hot news in the last couple of weeks I’m keen to get your views. More time for the public to learn about ‘information sharing, the benefits and their right to object’ is now ahead. I believe that the use of NHS patient data in clinical research will be a significant differentiator in maintaining the UK as an attractive global location for life science and I’m glad that lots of powerful voices from the UK science, clinical, research and patient community are joining together to help explain to the public how information can be used for medical research and will be kept safe.

If you are not in London this week I hope you can join my monthly webinar on Thursday. Alongside my regular policy update, I will be joined by Caroline Briggs, Managing Director, Amici Procurement. Caroline will help members understand how they can help grow their business effectively through using the BIA’s business solutions programme and Amici’s procurement solutions. Register on our website.

Looking further ahead on 3 April I will be speaking at the SynBioBeta conference in London. Last year a number of synthetic biology companies joined the BIA and we have been supporting them through our Synthetic Biology Advisory Committee and by supporting events such as SynBioBeta and the mission to the Bay Area last November, this is a great event to understand the vibrant UK company scene in this emerging area. For details of the discount for BIA members visit our website.

Best
Steve